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Background: Edentulism and sleep disturbance are chronic conditions that are common in older people and have
serious adverse consequences for their functioning and quality of life. Edentulism can disturb sleep through the
alteration of the craniofacial structure and surrounding soft tissue. However, the effect of prosthetic rehabilitation of
edentulism on sleep quality is still not well understood. The objectives of this study are to test whether nocturnal
denture wear affects sleep quality, daytime sleepiness, and the oral health related quality of life of edentate older
people with moderate to severe sleep apnea, and to identify modifiers of effect of nocturnal denture wear.
Methods/design: We will carry out a single-blind randomized cross-over trial. Seventy edentate older people with
moderate to severe obstructive sleep apnea will be enrolled. The study participants will be assigned to wear and
not wear their dentures on alternate periods of 30 days. The outcome measures will be sleep quality (assessed by
portable polysomnography), daytime sleepiness (assessed by the Epworth Sleepiness Scale), and oral health related
quality of life (assessed by validated questionnaire). A number of characteristics (sociodemographic, oropharyngeal
morphology, oral and prosthesis characteristics, and perceived general health quality of life) will be assessed by
means of clinical examination, 3D imaging of the craniofacial structure, and validated questionnaires at baseline.
Linear mixed effects regression models for repeated measures will be fitted to test the study hypotheses. The
main analyses will be based on the intention-to-treat principle. To assess the robustness of the findings to potential
incomplete adherence, sensitivity analyses will be conducted while applying the per-protocol principle.
Discussion: This practice-relevant evidence could represent a preventive approach to improve sleep characteristics of
the older population and improve their well-being and quality of life.
Trial registration: ClinicalTrials.gov NCT01868295.
Keywords: Complete denture, edentulism, obstructive sleeping apnea, oral health related quality of life, sleep
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The worldwide population is rapidly aging, with the ma-
jority of older people living longer than previous genera-
tions [1]. Aging substantially increases the risk of tooth
loss and sleep disturbance. In Canada, about one in four
people aged 65 and older is completely toothless [2], and* Correspondence: elham.emami@umontreal.ca
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unless otherwise stated.nearly half of all older people complain of disturbed
sleep [3,4]. These two chronic conditions have serious
adverse consequences for well-being, functioning, and
quality of life, and place a significant burden on the
health care system [5-8]. The costs associated with sleep
disturbance and tooth loss are also substantial [7,9-12].
The relationship between edentulism and sleep dis-
turbance and sleep-disordered breathing has been well
documented [13,14]. In fact, anatomical changes associ-
ated with edentulism and decrease in the vertical dimen-
sion of occlusion can negatively influence sleep and leadLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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dimension of occlusion leads to a forward and upward
mandibular position associated with a backward shift in
the supine position [16,19]. This rotational movement of
the mandible favors a shift of the tongue and soft palate
against the posterior pharyngeal wall. The reduction in
the retropharyngeal space associated with impaired func-
tion of the upper airway dilatation muscles results in
upper airway resistance, and diminished response to nega-
tive pressure stimulation [20-22]. Moreover, age-specific
compromised pharyngeal anatomy, upper airway mucosal
sensory dysfunction, and a decline in pharyngeal sensory
discrimination and reflexes have been proposed as being
responsible for the vulnerability of edentate elders to air-
way collapse [23-25]. Furthermore, the literature suggests
that there is a possible association between sleep disturb-
ance and wearing a complete denture during sleep, which
may explain the mechanism underlying the relationship
between obstructive sleep apnea and edentate individuals
[26,27]. One hypothesized effect was that the use of a den-
ture during sleep may lead to open bite and mouth
breathing with a decrease in the tone of the pharyngeal
muscles, thus leading to the development or worsening of
obstructive sleep apnea [28]; an alternative hypothesis
holds that sleep quality and pharyngeal patency are main-
tained by nocturnal denture use. Moreover, this denture
effect appears to be different between healthy edentate
older people and those with sleep disturbances [29]. How-
ever, there is a general belief amongst oral health care pro-
fessionals that edentate individuals should remove their
dentures at night. In fact, numerous studies have demon-
strated that long-term nocturnal wearing of dentures can
reduce the protective effect of saliva and obstruct good
oxygenation of the oral mucosa, which makes it less resist-
ant to mechanical and microbiological aggression, thus in-
creasing the risk of chronic inflammatory changes within
the mucosa [30-32]. This leads to an increased risk of
traumatic ulcers, denture stomatitis, and alveolar bone re-
sorption in the edentate population [33-37].
However, tooth loss and not wearing dentures at night
have not been recognized as a risk factor for sleep disturb-
ance and obstructive sleep apnea. Furthermore, the limited
quality of studies on this topic (graded as level ≤3 on the
Oxford level of grade of evidence) [38] do not permit clini-
cians to engage in evidence-based clinical decision-making.
This lack of knowledge poses legal and ethical problems
for clinicians and other dental professionals who are in-
volved in the care of the growing edentate population.
To enable development of clinical practice guidelines,
solid evidence is required. Specifically, a rigorous random-
ized trial is needed to help determine the effects of den-
ture wearing on patient-relevant outcomes [28,39-41].
To address this need, we have designed a single-blind
randomized cross-over trial. The first objective of thestudy is to test whether nocturnal denture wear has an
effect on sleep quality and daytime sleepiness of edentate
older people with moderate to severe sleep apnea. The
second objective is to test whether nocturnal denture
wear has an effect on the oral health related quality of
life of edentate older people with moderate to severe
sleep apnea. The third objective is to identify modifiers
of the putative effects of nocturnal denture wear.
Methods/design
The study protocol was approved by the Research Ethics
Board of Health of the Université de Montréal (Project
13-076-CERES-D). The trial is registered in the US
Clinical Trials Registry NCT01868295.
Recruitment process
Participants will be recruited from the area of metropol-
itan Montreal. Participants will be recruited through the
research, prosthodontics, and sleep apnea clinics of the
Université de Montréal, associated hospitals, geriatric in-
stitutes, and private sleep clinics.
The research coordinator will contact the patients in
person at the clinics with a study information brochure
to invite them to participate in the trial. Potential study
participants will be asked to contact a research coordin-
ator via a dedicated phone number with voicemail. The
research coordinator will describe the study in general
terms and assess major inclusion criteria, and the study
candidates will be invited to an in-person information
and screening session. During this session, the research
coordinator will inform these potential participants of
the general health risks associated with obstructive sleep
apnea and will explain all aspects of the study, using a
PowerPoint presentation and a study brochure. The in-
terested participants will be screened for eligibility for
inclusion in the study. Eligible participants will be asked
to read and sign a consent form. Informed consent will
be obtained from each eligible participant before pro-
ceeding with the trial.
Inclusion and exclusion criteria
Inclusion criteria
To be considered for inclusion in the study, the subject
must: (1) be aged 65 years or older; (2) have worn a
complete set of removable dentures in the past year but
not have worn the dentures during sleep in that period;
(3) have an Apnea-Hypopnea Index (AHI) score of at
least 15 at screening; (4) have an adequate understand-
ing of written and spoken English or French; (5) be able
to understand and respond to the questionnaires used in
the study; (6) agree to follow the research study instruc-
tions; (7) agree to adhere to the allocated sequence of in-
terventions; (8) consume no alcohol and (9) not work
late at night on the day before polysomnography.
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The participants are excluded if they: (1) have an AHI score
less than 15; (2) have any severe cardiologic, neurologic, psy-
chological, or psychiatric condition, respiratory disease, acute
airway infection, or any other health condition that jeopar-
dizes sleep; (3) score 24 or less on the Mini-Mental State
Evaluation [42]; (4) regularly consume more than two (for
women) or three (for men) alcoholic beverages per day; (5)
are taking medication or any illicit drug that will affect sleep
architecture or respiratory muscle activity (that is, hypnotics,
psychostimulants, anticonvulsant, or antipsychotics); (6) are
receiving regular continuous positive airway pressure therapy
or nocturnal supplemental oxygen; (7) have sleepiness
deemed to be unsafe and requiring urgent treatment; or (8)
feel that the trial would negatively influence their private life.
Intervention, randomization, allocation concealment, and
sequence generation
A single-blind randomized cross-over clinical trial will














Figure 1 Trial design.Eligible study participants will be randomly assigned
to wear or not wear their complete dentures at night, al-
ternately, for two periods of 30 days (Figure 1). Minimal
or no carry-over effect is expected based on the action
of the postulated mechanism of intervention [28] (add-
itional analyses of raw data from research team member
FRA: Grizzle’s model [43] sequence effect P = 0.8, period
effect P = 0.9, intervention effect P = 0.002). Therefore,
no wash-out period was deemed necessary.
To achieve a balanced allocation of participants in each
sequence, a permuted block randomization with varying
block sizes using SAS® PROC PLAN will be used [44-51].
Randomization and administration of opaque sequential
envelopes will be carried out off-site. The sleep technolo-
gist will deliver these envelopes to study participants at
their homes. Each participant will receive a sequentially
numbered, sealed, opaque, tamper-proof envelope indicat-
ing the sequence of intervention, and intervention will
start on the same day (one week after baseline assess-
ment). All the investigators, the research coordinator,
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recorded, and entered in a blinded fashion. Blinding will
be lifted once data analysis is complete. Although it is not
possible for the participants to be ‘blind’ to the interven-
tion, they will be asked not to discuss their interventions
with any research staff. Any question from participants
during the intervention period will be answered by two in-
dependent prosthodontists and, if necessary, a sleep clin-
ician, as these individuals will not be involved in data
collection or data analyses.Data collection
Persons who consent to participate in the study will be
invited to visit the clinical research laboratories of the
Faculty of Dental Medicine at the Université de Mon-
tréal at their convenience. During this visit, one trained
and calibrated research trainee will conduct baseline
data collection, including a clinical examination, admin-
istration of study questionnaires, and cone-beam com-
puted tomography (CBCT) (NewTom 5G CBCT, QR S.
r.l.-Verona, Italy), as described. Then, in the same week,
they will undergo one baseline portable overnight re-
cording (level II polysomnography) [52]. Follow-up data
will be collected at the end of each period by the sleep
technologist at home by means of one portable overnight
recording and the outcome questionnaires. The sleep tech-
nologist will install the device at the participants’ homes on
the evening of recording, verifying electrode impedance
and signal quality. This approach will allow us to maximize
the participation of older people and will increase their ad-
herence to the study procedures [53].Primary outcome measures
The selection of the outcomes was based on a literature
review and consultation with experts in sleep and oral
health disease [54,55].
The primary outcome is a change in sleep quality, as
measured by the AHI index. This index is a marker of
sleep quality that represents the number of apneic and
hypopneic incidents per hour of sleep [56]. The AHI
index will be measured using diagnostic portable poly-
somnography units for overnight home use [57]. Stand-
ard polysomnography measurements will include total
sleep duration, sleep efficiency, sleep onset latency, electro-
encephalogram arousal index, spontaneous arousals, and
sleep-stage distribution. Upon return of the device, poly-
somnographic data will be downloaded and scored using
REMLogic software (Embla Inc., Canada) to assess AHI,
snoring index, respiratory disturbance index, flow limita-
tion, respiratory efforts related arousals, and average and
minimal oxygen saturation. These respiratory events will
be scored by Sleep Strategies Inc. (Canada), according to
American Academy of Sleep Medicine guidelines [58].Secondary outcome measures
Secondary outcomes will be changes in daytime sleepi-
ness and oral health related quality of life.
The Epworth Sleepiness Scale (ESS) will be used to as-
sess perceived daytime sleepiness. The ESS is an eight-
item, four-point scale (0 to 3) with strong internal
consistency (Cronbach’s α = 0.81) and half-split reliability
(r = 0.82) [59]. Participants will be asked to rate their
chance of dozing in eight different sedentary situations.
Scores of 10 or more suggest excessive daytime sleepiness.
Oral health related quality of life will be measured by
means of the Oral Health Impact Profile (OHIP-20) [60].
This instrument is a disease-specific measure of people’s
perceptions of the impact of denture wear on physical,
psychological, and social aspects of their quality of life.
This validated and highly reliable (α = 0.88) oral health
disease-specific instrument has been widely used in geri-
atric dental research [61-63] and has been tested and
validated in English- and French-speaking Canadians for
cross-cultural validity. The range of the scale is 20 to
120 points, with lower scores indicating a better oral
health related quality of life [60,64].
The primary and secondary outcome measures will be
determined at baseline and at the end of each 30-day
period.
Covariates
We will also collect data on sociodemographic, medical,
and anthropometric (weight, height) characteristics, oro-
pharyngeal morphology (measured by a three-dimensional
imaging system, CBCT), as well as edentulism-associated
characteristics (vertical dimension of occlusion according
to prosthodontic standard criteria, history of tooth loss,
history of denture use, and nocturnal denture wear) [65]
and general health. Perceived general health will be
assessed using the Short Form-36 (SF-36) [66]. This is
a generic self-administered questionnaire consisting of
eight multi-item subscales: physical functioning, social
functioning, role limitations due to physical health prob-
lems, and role limitations due to emotional problems,
mental health, vitality, pain, and general health percep-
tions. The SF-36 has excellent internal consistency and
discriminates between individuals with and without
chronic disease [66-68]. The computerized scoring sys-
tem will be used according to the user’s manual, in
which higher scores represent a better condition [69].
Sample size justification
Assuming that (i) the minimal clinically important dif-
ference in the AHI score between the two interventions
is 5 events per hour (based on the opinion of expert cli-
nicians, Delphi method) [70], (ii) the standard deviation
of the distribution of the difference in AHI score be-
tween interventions is 10.6 events per hour (based on
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rate is 10% (based on our pilot data), a sample size of 70
study participants will ensure a 0.90 power to reject the null
hypothesis if it is indeed false, at a two-sided Bonferroni-
adjusted α level of 0.0167 (to account for the three study
outcomes).
The sample size of 70 would ensure a power of more
than 0.90 to detect a difference of 2.5 units in the mean
ESS score (assuming that the standard deviation is 3.5
units) [71], and a difference of 17 units (minimal clinic-
ally important difference) [72] in the mean OHIP score
(assuming that the standard deviation is 23.8 units) [73], at
a two-sided Bonferroni-adjusted α level of 0.0167 [74,75].
Statistical analysis
Descriptive analyses for all variables will be performed.
In case of apparent material deviations from normality,
the distributions of the dependent variables will be nor-
malized by appropriate transformations.
Mixed linear models will be fitted using SAS Proc
Mixed (SAS version 9.3, SAS Institute Inc., USA) to test
the associations between the intervention and each of
the study outcomes [76]. The model will include vari-
ables for intervention, randomization sequence, period,
and baseline value of the study outcome as fixed effects
and subject as a random effect. Hypotheses concerning
model parameters will be tested by Wald tests with an
approximate F null distribution.
To test for potential modification of the impact of the
intervention by determining the presence of sleep dis-
turbance at baseline, and the degree of sleep disturbance
at baseline, we will introduce a series of interaction
terms between the intervention status and each of these
characteristics (one at a time) into the above-described
linear models.
All of the analyses will be carried out in accordance with
the intention-to-treat principle, and various strategies will
be contemplated, to account for post-randomization miss-
ing data in the case of non-balanced missing data or attri-
tion of more than 10% of participants. However, in the
sensitivity analyses, we will also carry out per-protocol
analyses to assess the robustness of our findings to poten-
tial incomplete adherence: in particular, patients with
major protocol violations or poor adhere will be excluded.
Discussion
This research could inform planning for a preventive
approach to improve sleep characteristics of the older
population and, thereby, improve well-being and quality
of life. The evidence produced by this trial will assist in
producing truly evidence-based practice guidelines used
by primary care providers, dentists, and sleep medicine
specialists, who provide care for the millions of edentate
older people around the world [56].Trial status
The project is currently in the recruitment phase.
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